Magnet Biomedicine
Advancing precision medicine with molecular glues
Cambridge, United States · Founded 2023 · $50.0M raised
- Headquarters
- Cambridge, Massachusetts
- Founded
- 2023
- Website
- magnetbio.com
- Total Funding
- $50.0M
- Last Round
- $50.0M Series ASep 2023
- Rounds
- 1
About
Cambridge-based biotech using modular TrueGlue technology to discover molecular glues for the treatment of human disease.
Summary
Magnet Biomedicine is a Biotech company based in Cambridge, United States, founded in 2023. It has raised $50.0M in total across 1 round, most recently a $50.0M Series A round in Sep 2023. Investors include Newpath Management, ARCH Venture Partners and Taiho Ventures.
Tech & App Stack
3 technologies & apps tracked
Create a free account — 25 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 25 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Sep 2023
Investors
Similar Companies

Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.

China's leading mRNA biotech company developing therapeutics for cancer and infectious diseases.

Late-stage biopharma using single-molecule tracking, AI, and engineering to discover and develop ...
Global contract research organization providing comprehensive drug development and laboratory ser...

Global fertility clinics platform
Biopharmaceutical services company
